ANDA 210619

AMNEAL PHARMS LLC

FDA Drug Application

Application #210619

Application Sponsors

ANDA 210619

AMNEAL PHARMS LLC

Marketing Status

• Prescription: 001

Application Products

001

CAPSULE;ORAL

250MG

0

TRIENTINE HYDROCHLORIDE

TRIENTINE HYDROCHLORIDE

FDA Submissions

UNKNOWN;

ORIG

1

AP

2019-02-08

STANDARD

Submissions Property Types

ORIG

1

Null

7

TE Codes

001

Prescription

AB

CDER Filings

AMNEAL

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210619
            [companyName] => AMNEAL
            [docInserts] => ["",""]
            [products] => [{"drugName":"TRIENTINE HYDROCHLORIDE","activeIngredients":"TRIENTINE HYDROCHLORIDE","strength":"250MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"02\/08\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2019-02-08
        )

)